TY - JOUR
T1 - Do clinicians prescribe exercise similarly in patients with different cardiovascular diseases? Findings from the EAPC EXPERT working group survey
AU - Hansen, Dominique
AU - Rovelo Ruiz, Gustavo
AU - Doherty, Patrick Joseph
AU - Illiou, Marie-Christine
AU - Vromen, Tom
AU - Hinton, Sally
AU - Frederix, Ines
AU - Wilhelm, Matthias
AU - Schmid, Jean-Paul
AU - Abreu, Ana
AU - Ambrosetti, Marco
AU - Garcia-Porrero, Esteban
AU - Coninx, Karin
AU - Dendale, Paul
N1 - © The European Society of Cardiology 2018. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details
PY - 2018/2/28
Y1 - 2018/2/28
N2 - Background: Although disease-specific exercise guidelines for cardiovascular disease (CVD) are widely available, it
remains uncertain whether these different exercise guidelines are integrated properly for patients with different CVDs.
The aim of this study was to assess the inter-clinician variance in exercise prescription for patients with various CVDs
and to compare these prescriptions with recommendations from the EXercise Prescription in Everyday practice and
Rehabilitative Training (EXPERT) tool, a digital decision support system for integrated state-of-the-art exercise prescription
in CVD.
Design: The study was a prospective observational survey.
Methods: Fifty-three CV rehabilitation clinicians from nine European countries were asked to prescribe exercise
intensity (based on percentage of peak heart rate (HRpeak)), frequency, session duration, programme duration and
exercise type (endurance or strength training) for the same five patients. Exercise prescriptions were compared between
clinicians, and relationships with clinician characteristics were studied. In addition, these exercise prescriptions were
compared with recommendations from the EXPERT tool.
Results: A large inter-clinician variance was found for prescribed exercise intensity (median (interquartile range (IQR)):
83 (13) % of HRpeak), frequency (median (IQR): 4 (2) days/week), session duration (median (IQR): 45 (18) min/session),
programme duration (median (IQR): 12 (18) weeks), total exercise volume (median (IQR): 1215 (1961) peak-effort
training hours) and prescription of strength training exercises (prescribed in 78% of all cases). Moreover, clinicians’
exercise prescriptions were significantly different from those of the EXPERT tool (p < 0.001).
Conclusions: This study reveals significant inter-clinician variance in exercise prescription for patients with different
CVDs and disagreement with an integrated state-of-the-art system for exercise prescription, justifying the need for
standardization efforts regarding integrated exercise prescription in CV rehabilitation.
AB - Background: Although disease-specific exercise guidelines for cardiovascular disease (CVD) are widely available, it
remains uncertain whether these different exercise guidelines are integrated properly for patients with different CVDs.
The aim of this study was to assess the inter-clinician variance in exercise prescription for patients with various CVDs
and to compare these prescriptions with recommendations from the EXercise Prescription in Everyday practice and
Rehabilitative Training (EXPERT) tool, a digital decision support system for integrated state-of-the-art exercise prescription
in CVD.
Design: The study was a prospective observational survey.
Methods: Fifty-three CV rehabilitation clinicians from nine European countries were asked to prescribe exercise
intensity (based on percentage of peak heart rate (HRpeak)), frequency, session duration, programme duration and
exercise type (endurance or strength training) for the same five patients. Exercise prescriptions were compared between
clinicians, and relationships with clinician characteristics were studied. In addition, these exercise prescriptions were
compared with recommendations from the EXPERT tool.
Results: A large inter-clinician variance was found for prescribed exercise intensity (median (interquartile range (IQR)):
83 (13) % of HRpeak), frequency (median (IQR): 4 (2) days/week), session duration (median (IQR): 45 (18) min/session),
programme duration (median (IQR): 12 (18) weeks), total exercise volume (median (IQR): 1215 (1961) peak-effort
training hours) and prescription of strength training exercises (prescribed in 78% of all cases). Moreover, clinicians’
exercise prescriptions were significantly different from those of the EXPERT tool (p < 0.001).
Conclusions: This study reveals significant inter-clinician variance in exercise prescription for patients with different
CVDs and disagreement with an integrated state-of-the-art system for exercise prescription, justifying the need for
standardization efforts regarding integrated exercise prescription in CV rehabilitation.
U2 - 10.1177/2047487318760888
DO - 10.1177/2047487318760888
M3 - Article
SN - 2047-4873
JO - European journal of preventive cardiology
JF - European journal of preventive cardiology
ER -